NDC 71384-502

Pred-Gati

Prednisolone Acetate-gatifloxacin

Pred-Gati is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Gatifloxacin; Prednisolone Acetate.

Product ID71384-502_6389e970-c7dd-958e-e053-2a91aa0acb11
NDC71384-502
Product TypeHuman Prescription Drug
Proprietary NamePred-Gati
Generic NamePrednisolone Acetate-gatifloxacin
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2018-01-05
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameImprimis NJOF, LLC
Substance NameGATIFLOXACIN; PREDNISOLONE ACETATE
Active Ingredient Strength5 mg/mL; mg/mL
Pharm ClassesQuinolone Antimicrobial [EPC],Quinolones [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71384-502-03

20 BOTTLE, DROPPER in 1 BOX (71384-502-03) > 3.5 mL in 1 BOTTLE, DROPPER
Marketing Start Date2018-01-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71384-502-03 [71384050203]

Pred-Gati SUSPENSION/ DROPS
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-01-05
Marketing End Date2019-07-01
Inactivation Date2020-01-31
Reactivation Date2020-02-12

Drug Details

Active Ingredients

IngredientStrength
GATIFLOXACIN5 mg/mL

OpenFDA Data

SPL SET ID:6326b43a-bbac-4696-e053-2a91aa0a73fb
Manufacturer
UNII

Pharmacological Class

  • Quinolone Antimicrobial [EPC]
  • Quinolones [CS]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

NDC Crossover Matching brand name "Pred-Gati" or generic name "Prednisolone Acetate-gatifloxacin"

NDCBrand NameGeneric Name
70261-502Pred-GatiPrednisolone-Gatifloxacin
71384-502Pred-GatiPrednisolone Acetate-Gatifloxacin

Trademark Results [Pred-Gati]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PRED-GATI
PRED-GATI
87180492 5342159 Live/Registered
HARROW IP, LLC
2016-09-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.